PMC Links for Books (Select 4854546) - PMC

Links from Books

Items: 1 to 20 of 41

<< First< Prev

Page of 3

Select item 54974921.

Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?

Adrian M. Di Bisceglie, Anna S. Lok, Paul Martin, Norah Terrault, Robert P. Perrillo, Jay H. Hoofnagle

Hepatology. Author manuscript; available in PMC 2017 Jul 5.

Published in final edited form as: Hepatology. 2015 Feb; 61(2): 703–711. doi: 10.1002/hep.27609

PMCID:: PMC5497492

Abstract Article PDF–430K

Select item 46273922.

Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

Rogerio Serafim Parra, Marley Ribeiro Feitosa, Vanessa Foresto Machado, Leandra Naira Zambelli Ramalho, Jose Joaquim Ribeiro da Rocha, Omar Feres

J Med Case Rep. 2015; 9: 249. Published online 2015 Oct 30. doi: 10.1186/s13256-015-0730-5

PMCID:: PMC4627392

Abstract Article PDF–1.3M

Select item 45540523.

Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants: A French Retrospective Multicenter Study

Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, Sophie Fournier, Florence Abravanel, Alain Cantagrel, Emmanuel Chatelus, Pascal Claudepierre, Christophe Hudry, Jacques Izopet, Sylvie Fabre, Guillaume Lefevre, Laurent Marguerie, Antoine Martin, Laurent Messer, Anna Molto, Béatrice Pallot-Prades, Yves-Marie Pers, Anne-Marie Roque-Afonso, Christian Roux, Christelle Sordet, Martin Soubrier, Claire Veissier, Daniel Wendling, Jean-Marie Péron, Jean Sibilia

Medicine (Baltimore) 2015 Apr; 94(14): e675. Published online 2015 Apr 10. doi: 10.1097/MD.0000000000000675

PMCID:: PMC4554052

Abstract Article PDF–129K

Select item 44814564.

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

Susana Rodrigues, Susana Lopes, Fernando Magro, Hélder Cardoso, Ana Maria Horta e Vale, Margarida Marques, Eva Mariz, Miguel Bernardes, Joanne Lopes, Fátima Carneiro, Guilherme Macedo

World J Gastroenterol. 2015 Jun 28; 21(24): 7584–7588. Published online 2015 Jun 28. doi: 10.3748/wjg.v21.i24.7584

PMCID:: PMC4481456

Abstract Article PDF–897K

Select item 44462355.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 43459086.

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, Arthur Kavanaugh

Ann Rheum Dis. 2015 Mar; 74(3): 538–546. Published online 2013 Dec 16. doi: 10.1136/annrheumdis-2013-204195

PMCID:: PMC4345908

Abstract Article PDF–371K

Select item 42655937.

Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management

Roberta Elisa Rossi, Ioanna Parisi, Edward John Despott, Andrew Kenneth Burroughs, James O'Beirne, Dario Conte, Mark Ian Hamilton, Charles Daniel Murray

World J Gastroenterol. 2014 Dec 14; 20(46): 17352–17359. Published online 2014 Dec 14. doi: 10.3748/wjg.v20.i46.17352

PMCID:: PMC4265593

Abstract Article PDF–1.1M

Select item 41124448.

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, Sarvajeet Pal, Jürgen Wollenhaupt, Cristiano A F Zerbini, Andre D Beaulieu, Hendrik Schulze-Koops, Patrick Durez, Ruji Yao, Nathan Vastesaeger, Haoling H Weng

Ann Rheum Dis. 2014 Aug; 73(8): 1477–1486. Published online 2013 Jun 5. doi: 10.1136/annrheumdis-2013-203229

PMCID:: PMC4112444

Abstract Article PDF–1.8M

Select item 40661689.

Subfulminant hepatitis B after infliximab in Crohn’s disease: Need for HBV-screening?

Gunda Millonig, Michaela Kern, Othmar Ludwiczek, Karin Nachbaur, Wolfgang Vogel

World J Gastroenterol. 2006 Feb 14; 12(6): 974–976. Published online 2006 Feb 14. doi: 10.3748/wjg.v12.i6.974

PMCID:: PMC4066168

Abstract Article PDF–637K

Select item 399225010.

Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study

Adrian Reuben, David G. Koch, William M. Lee, the Acute Liver Failure Study Group

Hepatology. Author manuscript; available in PMC 2014 Apr 20.

Published in final edited form as: Hepatology. 2010 Dec; 52(6): 2065–2076. Published online 2010 Oct 14. doi: 10.1002/hep.23937

PMCID:: PMC3992250

Abstract Article PDF–328K

Select item 396626011.

Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature

Ravish Parekh, Nirmal Kaur

Case Rep Gastrointest Med. 2014; 2014: 956463. Published online 2014 Jan 19. doi: 10.1155/2014/956463

PMCID:: PMC3966260

Abstract Article PDF–1.0M

Select item 386570212.

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

MARWAN GHABRIL, HERBERT L. BONKOVSKY, CLARISSA KUM, TIM DAVERN, PAUL H. HAYASHI, DAVID E. KLEINER, JOSE SERRANO, JIM ROCHON, ROBERT J. FONTANA, MAURIZIO BONACINI

Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2014 May 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2013 May; 11(5): 10.1016/j.cgh.2012.12.025. Published online 2013 Jan 17. doi: 10.1016/j.cgh.2012.12.025

PMCID:: PMC3865702

Abstract Article PDF–515K

Select item 384813413.

Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review

Maurizio Pompili, Marco Biolato, Luca Miele, Antonio Grieco

World J Gastroenterol. 2013 Nov 28; 19(44): 7867–7873. Published online 2013 Nov 28. doi: 10.3748/wjg.v19.i44.7867

PMCID:: PMC3848134

Abstract Article PDF–1.0M

Select item 382399914.

Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

Joerg Latus, Reinhild Klein, Ina Koetter, Matthias Schwab, Peter Fritz, Martin Kimmel, M. Dominik Alscher, Niko Braun

PLoS One. 2013; 8(11): e78856. Published online 2013 Nov 11. doi: 10.1371/journal.pone.0078856

PMCID:: PMC3823999

Abstract Article PDF–538K

Select item 381286415.

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

Arthur Kavanaugh, Iain B McInnes, Philip J Mease, Gerald G Krueger, Dafna D Gladman, Désirée van der Heijde, Surekha Mudivarthy, Weichun Xu, Michael Mack, Zhenhua Xu, Anna Beutler

Ann Rheum Dis. 2013 Nov; 72(11): 1777–1785. Published online 2012 Nov 17. doi: 10.1136/annrheumdis-2012-202035

PMCID:: PMC3812864

Abstract Article PDF–1.3M

Select item 381246316.

Severe cholestasis due to adalimumab in a Crohn’s disease patient

Edward Kim, Brian Bressler, David F Schaeffer, Eric M Yoshida

World J Hepatol. 2013 Oct 27; 5(10): 592–595. Published online 2013 Oct 27. doi: 10.4254/wjh.v5.i10.592

PMCID:: PMC3812463

Abstract Article PDF–1.1M

Select item 378065217.

Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy

Satoshi Nakayama

Case Rep Med. 2013; 2013: 561748. Published online 2013 Sep 8. doi: 10.1155/2013/561748

PMCID:: PMC3780652

Abstract Article PDF–717K

Select item 365424418.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, for the Drug Induced Liver Injury Network (DILIN)

Gastroenterology. Author manuscript; available in PMC 2013 May 15.

Published in final edited form as: Gastroenterology. 2008 Dec; 135(6): 1924–1934.e4. Published online 2008 Sep 17. doi: 10.1053/j.gastro.2008.09.011

PMCID:: PMC3654244

Abstract Article PDF–96K

Select item 362338619.

Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients

R. Laurenti, F. Giovannangeli, E. Gubinelli, M. T. Viviano, A. Errico, L. Leoni, E. Ballanti, A. Migliore

Clin Dev Immunol. 2013; 2013: 410521. Published online 2013 Mar 27. doi: 10.1155/2013/410521

PMCID:: PMC3623386

Abstract Article PDF–472K

Select item 359482020.

Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis

Hiroko Kuwabara, Akira Fukuda, Yasuhiro Tsuda, Yuro Shibayama

Clin Rheumatol. 2013; 32(Suppl 1): 47–49. Published online 2010 Apr 9. doi: 10.1007/s10067-010-1438-y

PMCID:: PMC3594820

Abstract Article PDF–186K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 1 to 20 of 41

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity